Login / Signup

Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients.

Ji-Gan WangRui ChenLi-Chuan Wang
Published in: Alimentary pharmacology & therapeutics (2021)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • hepatitis b virus
  • peritoneal dialysis
  • prognostic factors
  • liver fibrosis